Moise’s interest in fetal therapy spans a 30-year period. He is recognized worldwide for his contributions in the fetal treatment of Rh disease including the development of middle cerebral artery Doppler for the noninvasive detection of fetal anemia and the use of free fetal DNA to determine the fetal RHD status in the U.S. He was instrumental in the formation of three fetal centers: the Center for Maternal and Infant Health at the University of North Carolina, the Texas Children’s Fetal Center in Houston and the Fetal Center at Children’s Memorial Hermann Hospital in Houston. In 2019, he was awarded the Lifetime Achievement Award by the Society for Maternal-Fetal Medicine for his work in hemolytic disease of the fetus and newborn.